Ocugen Inc (OCGN) concluded trading on Thursday at a closing price of $0.95, with 11.05 million shares of worth about $10.49 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 0.96% during that period and on Thursday the price saw a gain of about 7.41%. Currently the company’s common shares owned by public are about 292.03M shares, out of which, 286.77M shares are available for trading.
Stock saw a price change of 14.23% in past 5 days and over the past one month there was a price change of 33.24%. Year-to-date (YTD), OCGN shares are showing a performance of 18.37% which decreased to -43.95% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $1.98 during that period. The average intraday trading volume for Ocugen Inc shares is 4.12 million. The stock is currently trading 17.50% above its 20-day simple moving average (SMA20), while that difference is up 28.17% for SMA50 and it goes to 12.31% higher than SMA200. Ocugen Inc (NASDAQ: OCGN) currently have 292.03M outstanding shares and institutions hold larger chunk of about 26.40% of that.
The stock has a current market capitalization of $278.28M and its 3Y-monthly beta is at 4.24. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 2.60 while making debt-to-equity ratio of 2.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OCGN, volatility over the week remained 3.05% while standing at 4.20% over the month.
Stock’s fiscal year EPS is expected to drop by -15.00% while it is estimated to decrease by -4.35% in next year. EPS is likely to grow at an annualized rate of 46.87% for next 5-years, compared to annual growth of 32.82% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on October 15, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. Coverage by Chardan Capital Markets stated Ocugen Inc (OCGN) stock as a Buy in their note to investors on March 01, 2023, suggesting a price target of $3.50 for the stock. On August 23, 2022, Mizuho Initiated their recommendations, while on June 15, 2022, ROTH Capital Resumed their ratings for the stock with a price target of $8. Stock get an Overweight rating from Cantor Fitzgerald on June 02, 2022.
